• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

外视网膜膜蛋白 1 可作为肿瘤抑制因子抑制肺癌进展。

The Outer Retinal Membrane Protein 1 Could Inhibit Lung Cancer Progression as a Tumor Suppressor.

机构信息

Department of Respiratory Medicine, The Second Affiliated Hospital of Zhejiang University School of Medicine, 88 Jiefang Road, 310009 Hangzhou, Zhejiang, China.

State Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai 200438, China.

出版信息

Comput Math Methods Med. 2021 Feb 17;2021:6651764. doi: 10.1155/2021/6651764. eCollection 2021.

DOI:10.1155/2021/6651764
PMID:33680068
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7904357/
Abstract

Some related reports indicate that the outer retinal membrane protein 1 (ROM1) functions importantly in the regulation of the biological process of tumor. Nevertheless, studies towards the role of ROM1 in lung cancer are few. Here, our data demonstrated that ROM1 displayed a relation with lung cancer tumorigenesis and development. In the Tumor Genome Atlas (TCGA) cohort, reduced ROM1 level was observed in lung cancer tissues, instead of normal tissues. After bioinformatics analysis, the data revealed that ROM1 level was associated with the tumor stage. Additional results indicated that highly expressed ROM1 exhibited a positive correlation with the overall survival rate, and ROM1 was probably a promising prognostic biomarker of lung cancer. Additionally, our results indicated that knocking out ROM1 could promote cell proliferation, migration, and invasion. Our data conclusively demonstrated that ROM1 modulated lung cancer tumorigenesis and development, as a prognosis and treatment biomarker.

摘要

一些相关报道表明,外视网膜膜蛋白 1(ROM1)在肿瘤的生物过程调控中具有重要作用。然而,关于 ROM1 在肺癌中的作用的研究较少。在这里,我们的数据表明 ROM1 与肺癌的发生和发展有关。在肿瘤基因组图谱(TCGA)队列中,肺癌组织中观察到 ROM1 水平降低,而正常组织中则没有。经过生物信息学分析,数据显示 ROM1 水平与肿瘤分期有关。进一步的结果表明,高表达的 ROM1 与总生存率呈正相关,ROM1 可能是肺癌有前途的预后生物标志物。此外,我们的结果表明,敲除 ROM1 可以促进细胞增殖、迁移和侵袭。我们的数据最终表明,ROM1 调节肺癌的发生和发展,可作为预后和治疗的生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52e1/7904357/d585c55d8cd1/CMMM2021-6651764.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52e1/7904357/eb83d109fae5/CMMM2021-6651764.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52e1/7904357/4261024a675e/CMMM2021-6651764.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52e1/7904357/aa2da120e774/CMMM2021-6651764.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52e1/7904357/b6642a619e6d/CMMM2021-6651764.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52e1/7904357/d585c55d8cd1/CMMM2021-6651764.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52e1/7904357/eb83d109fae5/CMMM2021-6651764.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52e1/7904357/4261024a675e/CMMM2021-6651764.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52e1/7904357/aa2da120e774/CMMM2021-6651764.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52e1/7904357/b6642a619e6d/CMMM2021-6651764.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52e1/7904357/d585c55d8cd1/CMMM2021-6651764.005.jpg

相似文献

1
The Outer Retinal Membrane Protein 1 Could Inhibit Lung Cancer Progression as a Tumor Suppressor.外视网膜膜蛋白 1 可作为肿瘤抑制因子抑制肺癌进展。
Comput Math Methods Med. 2021 Feb 17;2021:6651764. doi: 10.1155/2021/6651764. eCollection 2021.
2
Cyclin H Regulates Lung Cancer Progression as a Carcinoma Inducer.周期蛋白 H 作为致癌诱导物调节肺癌进展。
Comput Math Methods Med. 2021 Mar 9;2021:6646077. doi: 10.1155/2021/6646077. eCollection 2021.
3
LSR Promotes Cell Proliferation and Invasion in Lung Cancer.LSR 促进肺癌细胞增殖和侵袭。
Comput Math Methods Med. 2021 Mar 8;2021:6651907. doi: 10.1155/2021/6651907. eCollection 2021.
4
LATS2 as a poor prognostic marker regulates non-small cell lung cancer invasion by modulating MMPs expression.LATS2 作为一个不良预后标志物,通过调节 MMPs 的表达来调控非小细胞肺癌的侵袭。
Biomed Pharmacother. 2016 Aug;82:290-7. doi: 10.1016/j.biopha.2016.04.008. Epub 2016 May 17.
5
TPX2 Promotes Metastasis and Serves as a Marker of Poor Prognosis in Non-Small Cell Lung Cancer.TPX2促进非小细胞肺癌转移并作为预后不良的标志物。
Med Sci Monit. 2020 Aug 4;26:e925147. doi: 10.12659/MSM.925147.
6
BRCA1-associated protein 1 deficiency in lung adenocarcinoma predicts poor outcome and increased tumor invasion.肺腺癌中BRCA1相关蛋白1缺乏预示预后不良及肿瘤侵袭增加。
BMC Cancer. 2016 Aug 23;16(1):670. doi: 10.1186/s12885-016-2670-x.
7
ROM1 contributes to phenotypic heterogeneity in PRPH2-associated retinal disease.ROM1 导致 PRPH2 相关的视网膜疾病的表型异质性。
Hum Mol Genet. 2020 Sep 29;29(16):2708-2722. doi: 10.1093/hmg/ddaa160.
8
The molecular impact of pigment epithelium-derived factor, PEDF, on lung cancer cells and the clinical significance.色素上皮衍生因子(PEDF)对肺癌细胞的分子影响及临床意义。
Int J Oncol. 2009 Jul;35(1):159-66. doi: 10.3892/ijo_00000324.
9
Depleting PTOV1 sensitizes non-small cell lung cancer cells to chemotherapy through attenuating cancer stem cell traits.耗尽 PTOV1 通过减弱癌症干细胞特性使非小细胞肺癌细胞对化疗敏感。
J Exp Clin Cancer Res. 2019 Aug 6;38(1):341. doi: 10.1186/s13046-019-1349-y.
10
Coiled-coil domain-containing protein 8 inhibits the invasiveness and migration of non-small cell lung cancer cells.含卷曲螺旋结构域蛋白8抑制非小细胞肺癌细胞的侵袭和迁移。
Hum Pathol. 2016 Oct;56:64-73. doi: 10.1016/j.humpath.2016.06.001. Epub 2016 Jun 21.

引用本文的文献

1
Comprehensive analysis of gene expression profiles of annulus fibrosus subtypes and hub genes in intervertebral disc degeneration.全面分析纤维环亚型和椎间盘退变中枢纽基因的基因表达谱。
Aging (Albany NY). 2024 Mar 13;16(6):5370-5386. doi: 10.18632/aging.205653.
2
Tetraspanins as Potential Modulators of Glutamatergic Synaptic Function.四跨膜蛋白作为谷氨酸能突触功能的潜在调节因子。
Front Mol Neurosci. 2022 Jan 3;14:801882. doi: 10.3389/fnmol.2021.801882. eCollection 2021.

本文引用的文献

1
Bioinformatics analyses of retinoblastoma reveal the retinoblastoma progression subtypes.视网膜母细胞瘤的生物信息学分析揭示了视网膜母细胞瘤进展亚型。
PeerJ. 2020 May 21;8:e8873. doi: 10.7717/peerj.8873. eCollection 2020.
2
[Chinese expert consensus on the multidisciplinary clinical diagnosis and treatment of stage Ⅲ non-small cell lung cancer (2019)].《中国Ⅲ期非小细胞肺癌多学科临床诊断与治疗专家共识(2019年版)》
Zhonghua Zhong Liu Za Zhi. 2019 Dec 23;41(12):881-890. doi: 10.3760/cma.j.issn.0253-3766.2019.12.001.
3
Association of Patient Characteristics and Tumor Genomics With Clinical Outcomes Among Patients With Non-Small Cell Lung Cancer Using a Clinicogenomic Database.
基于临床基因组数据库的非小细胞肺癌患者的患者特征和肿瘤基因组与临床结局的相关性分析。
JAMA. 2019 Apr 9;321(14):1391-1399. doi: 10.1001/jama.2019.3241.
4
Immunotherapy in Non-Small Cell Lung Cancer: Facts and Hopes.非小细胞肺癌的免疫疗法:现状与展望
Clin Cancer Res. 2019 Aug 1;25(15):4592-4602. doi: 10.1158/1078-0432.CCR-18-1538. Epub 2019 Mar 1.
5
Current and Future Molecular Testing in NSCLC, What Can We Expect from New Sequencing Technologies?非小细胞肺癌当前及未来的分子检测,我们能从新测序技术中期待什么?
J Clin Med. 2018 Jun 9;7(6):144. doi: 10.3390/jcm7060144.
6
Bioinformatics and functional analyses of key genes and pathways in human clear cell renal cell carcinoma.人肾透明细胞癌关键基因和通路的生物信息学与功能分析
Oncol Lett. 2018 Jun;15(6):9133-9141. doi: 10.3892/ol.2018.8473. Epub 2018 Apr 12.
7
Dysregulation of mRNA translation and energy metabolism in cancer.癌症中mRNA翻译与能量代谢的失调。
Adv Biol Regul. 2018 Jan;67:30-39. doi: 10.1016/j.jbior.2017.11.001. Epub 2017 Nov 2.
8
Rom1 converts Y141C-Prph2-associated pattern dystrophy to retinitis pigmentosa.Rom1将Y141C-Prph2相关的图案性营养不良转化为色素性视网膜炎。
Hum Mol Genet. 2017 Feb 1;26(3):509-518. doi: 10.1093/hmg/ddw408.
9
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.转移性非小细胞肺癌:ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2016 Sep;27(suppl 5):v1-v27. doi: 10.1093/annonc/mdw326.
10
KRAS AND THE REALITY OF PERSONALIZED MEDICINE IN NON-SMALL CELL LUNG CANCER.KRAS与非小细胞肺癌个体化医疗的现状
Mol Med. 2016 Sep;22:380-387. doi: 10.2119/molmed.2016.00151. Epub 2016 Jul 7.